Enliven Therapeutics Inc (NASDAQ:ELVN)
| 22.95 BATS BZX Real-Time Price As of 3:07pm ET |  -0.05 / -0.22%Today’s Change | 3.90 Today|||52-Week Range 25.34 | +40.28% Year-to-Date |
Latest ELVN News | Press Releases
No recent news for Enliven Therapeutics Inc.
Today’s Trading
| Previous close | 23.00 |
| Today’s open | 23.32 |
| Day’s range | 22.91 - 23.50 |
| Volume | 1,403 |
| Average volume (3 months) | 46,241 |
| Market cap | $924.8M |
Data as of 3:07pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.60 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $1.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
